ABUS icon

Arbutus Biopharma
ABUS

Overview Fund Activity

51 hedge funds and large institutions have $61.1M invested in Arbutus Biopharma in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 6 closing their positions.

Holders
51
Holders Change
+2
Holders Change %
+4.08%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
17
Closed
6
Calls
$470K
Puts
$560K
Net Calls
-$90K
Net Calls Change
-$239K

Top Buyers

1
AC
1
Armistice Capital
New York
$1.42M
2
IGIM
2
I.G. Investment Management
Manitoba, Canada
$870K
3
Deutsche Bank
3
Deutsche Bank
Germany
$650K
4
Morgan Stanley
4
Morgan Stanley
New York
$347K
5
KPF
5
K2 Principal Fund
Ontario, Canada
$221K

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$2.04M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$272K
3
DCM
3
Dialectic Capital Management
Connecticut
$87K
4
SFM
4
Sphera Funds Management
Israel
$1.04M
5
BG
5
Bellevue Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CC
51
Caxton Corporation
New Jersey
– -$173K -41,903 Closed
AGM
52
Alpine Global Management
New York
– -$43K -10,434 Closed
WIC
53
Woodmont Investment Counsel
Tennessee
– -$3K -800 Closed
1 2
3